@article{0279dfc7a4a446ea81e231ed7c78b559,
title = "Reply",
author = "Brilakis, {Emmanouil S.} and Rao, {Sunil V.} and Subhash Banerjee and Steven Goldman and Shunk, {Kendrick A.} and Holmes, {David R.} and Emily Honeycutt and Roe, {Matthew T.}",
note = "Funding Information: Please note: Dr. Brilakis has received speaker honoraria from St. Jude Medical and Terumo; research support from Abbott Vascular and InfraRedx; and his spouse is an employee of Medtronic. Dr. Rao has received research funding Cordis Corporation, Momenta Pharmaceuticals, and Portola Pharmaceuticals; and speaker honoraria The Medicines Co., Sanofi Aventis, Bristol-Myers Squibb, and AstraZeneca. Dr. Banerjee has received speaker honoraria from St. Jude Medical, Medtronic, and Johnson & Johnson; and research support from Boston Scientific and The Medicines Co. Dr. Shunk has received research support from Abbott Vascular and Siemens Medical Systems; has stock options in Revascular Therapeutics; and has intellectual property rights licensed by SurgiVision, Inc. ",
year = "2011",
month = nov,
doi = "10.1016/j.jcin.2011.10.001",
language = "English (US)",
volume = "4",
pages = "1252",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "11",
}